Results 161 to 170 of about 11,525,512 (295)
Metabolic Dysfunction at the Core: Revisiting the Overlap of Cardiovascular, Renal, Hepatic, and Endocrine Disorders. [PDF]
Tanasescu MD +6 more
europepmc +1 more source
Objective We developed a novel EHR sidecar application to visualize key rheumatoid arthritis (RA) outcomes, including disease activity, physical function, and pain, via a patient‐facing graphical interface designed for use during outpatient visits (“RA PRO dashboard”).
Gabriela Schmajuk +16 more
wiley +1 more source
Physical modelling of propagation characteristics of blasting stress waves in rock masses with parallel and X-shaped intersecting joints. [PDF]
Deng Z +5 more
europepmc +1 more source
Parallel Mechanisms in Haptics
openaire +2 more sources
Objective Mycophenolate Mofetil (MMF) use in limited cutaneous systemic sclerosis (lcSSc) is relatively uncommon due to the lower fibrotic burden and the predominance of the vascular complications. In vitro observations and clinical data from transplanted patients suggest a protective effect of MMF on endothelial function.
Enrico De Lorenzis +77 more
wiley +1 more source
Predicting Low-Cycle Fatigue Life Using New Energy-Based Fatigue Damage Measures. [PDF]
Mroziński S +3 more
europepmc +1 more source
Design of Reconfigurable Parallel Mechanisms with Discontinuously Movable Mechanism
叶伟, 温如凤, 方跃法, 郭盛
semanticscholar +1 more source
Objective The objective of this study was to describe the longitudinal disease course and pulmonary outcomes of North American patients with melanoma differentiation‐associated gene 5 antibody (MDA5 ab) associated dermatomyositis (DM). Methods Thirty patients with MDA5 ab DM were identified in a single center longitudinal cohort of 352 patients with ...
Jenice X Cheah +8 more
wiley +1 more source
An Integrated Kinetic Modeling Framework for Copyrolysis of Biomass and Plastic Waste. [PDF]
Liu H, Alhumade H, Elkamel A.
europepmc +1 more source
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie +3 more
wiley +1 more source

